Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

JPAM (Jan) van Meerbeeck; R Gaafar; C Manegold; RJ Klaveren; EA van Marck; M Vincent; C Legrand; A Bottomley; C Debruyne; G Giaccone

doi:10.1200/JCO.20005.14.589

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

JPAM (Jan) van Meerbeeck, R Gaafar, C Manegold, RJ Klaveren, EA van Marck, M Vincent, C Legrand, A Bottomley, C Debruyne, G Giaccone

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

574 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	6881-6889
Number of pages	9
Journal	Journal of Clinical Oncology
Volume	23
Issue number	28
DOIs	https://doi.org/10.1200/JCO.20005.14.589
Publication status	Published - 2005

Research programs

EMC MM-04-42-02

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.20005.14.589

http://hdl.handle.net/1765/58431

Cite this

van Meerbeeck, JPAM., Gaafar, R., Manegold, C., Klaveren, RJ., van Marck, EA., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005). Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. Journal of Clinical Oncology, 23(28), 6881-6889. https://doi.org/10.1200/JCO.20005.14.589

van Meerbeeck, JPAM (Jan) ; Gaafar, R ; Manegold, C et al. / Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. In: Journal of Clinical Oncology. 2005 ; Vol. 23, No. 28. pp. 6881-6889.

@article{f808c07c909f4e6b8bd34327c0e76f00,

title = "Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada",

author = "{van Meerbeeck}, {JPAM (Jan)} and R Gaafar and C Manegold and RJ Klaveren and {van Marck}, EA and M Vincent and C Legrand and A Bottomley and C Debruyne and G Giaccone",

year = "2005",

doi = "10.1200/JCO.20005.14.589",

language = "Undefined/Unknown",

volume = "23",

pages = "6881--6889",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "28",

}

van Meerbeeck, JPAM, Gaafar, R, Manegold, C, Klaveren, RJ, van Marck, EA, Vincent, M, Legrand, C, Bottomley, A, Debruyne, C & Giaccone, G 2005, 'Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada', Journal of Clinical Oncology, vol. 23, no. 28, pp. 6881-6889. https://doi.org/10.1200/JCO.20005.14.589

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. / van Meerbeeck, JPAM (Jan); Gaafar, R; Manegold, C et al.
In: Journal of Clinical Oncology, Vol. 23, No. 28, 2005, p. 6881-6889.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

AU - van Meerbeeck, JPAM (Jan)

AU - Gaafar, R

AU - Manegold, C

AU - Klaveren, RJ

AU - van Marck, EA

AU - Vincent, M

AU - Legrand, C

AU - Bottomley, A

AU - Debruyne, C

AU - Giaccone, G

PY - 2005

Y1 - 2005

U2 - 10.1200/JCO.20005.14.589

DO - 10.1200/JCO.20005.14.589

M3 - Article

C2 - 16192580

SN - 0732-183X

VL - 23

SP - 6881

EP - 6889

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 28

ER -

van Meerbeeck JPAM, Gaafar R, Manegold C, Klaveren RJ, van Marck EA, Vincent M et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. Journal of Clinical Oncology. 2005;23(28):6881-6889. doi: 10.1200/JCO.20005.14.589